Published in Gut on June 22, 2012
L. Casei DG® in Patients With Irritable Bowel Syndrome. (PROBE2) | NCT03449628
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION) (LION) | NCT05100719
The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol (2012) 2.60
Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun (2015) 1.68
Gut/brain axis and the microbiota. J Clin Invest (2015) 1.64
Randomised controlled trial of mesalazine in IBS. Gut (2014) 1.58
Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology (2015) 1.56
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology (2015) 1.42
The gut microbiome in health and in disease. Curr Opin Gastroenterol (2015) 1.33
The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PLoS One (2014) 1.30
The human microbiome as a reservoir of antimicrobial resistance. Front Microbiol (2013) 1.27
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol (2015) 1.25
Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology (2014) 1.22
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. Aliment Pharmacol Ther (2013) 1.21
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19
Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol (2015) 1.14
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol (2015) 1.13
Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron (2015) 1.11
Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol (2015) 1.08
Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One (2014) 1.06
Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. Am J Gastroenterol (2016) 1.04
Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03
Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol (2014) 1.03
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol (2016) 1.02
Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol (2013) 1.01
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther (2015) 1.01
Irritable bowel syndrome in female patients is associated with alterations in structural brain networks. Pain (2013) 1.01
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol (2014) 1.00
Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis (2013) 0.99
Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy. Clin Exp Gastroenterol (2014) 0.99
The role of probiotics and prebiotics in inducing gut immunity. Front Immunol (2013) 0.99
Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterol J (2014) 0.97
Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol (2015) 0.97
Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol (2015) 0.97
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep (2015) 0.96
The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes (2014) 0.96
Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes (2014) 0.95
Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One (2015) 0.93
Irritable bowel syndrome: a concise review of current treatment concepts. World J Gastroenterol (2014) 0.92
New and Emerging Treatment Options for Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y) (2015) 0.91
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc (2016) 0.90
Beyond phylotyping: understanding the impact of gut microbiota on host biology. Neurogastroenterol Motil (2013) 0.90
Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol (2014) 0.89
Chronic Early-life Stress in Rat Pups Alters Basal Corticosterone, Intestinal Permeability, and Fecal Microbiota at Weaning: Influence of Sex. J Neurogastroenterol Motil (2016) 0.89
Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil (2016) 0.89
Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2016) 0.88
Drug development for the irritable bowel syndrome: current challenges and future perspectives. Front Pharmacol (2013) 0.88
Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol (2014) 0.88
Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet. Gut (2013) 0.87
Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol (2014) 0.87
Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection. PLoS One (2015) 0.87
Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne) (2014) 0.86
Small RNAs from plants, bacteria and fungi within the order Hypocreales are ubiquitous in human plasma. BMC Genomics (2014) 0.86
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.85
Fructose transporters GLUT5 and GLUT2 expression in adult patients with fructose intolerance. United European Gastroenterol J (2014) 0.84
The role of gut microbiota in the gut-brain axis: current challenges and perspectives. Protein Cell (2013) 0.84
Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children. Gastroenterol Hepatol Bed Bench (2015) 0.84
Hot topics in gut microbiota. United European Gastroenterol J (2013) 0.84
Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods. Korean J Intern Med (2014) 0.83
It's a gut feeling: how the gut microbiota affects the state of mind. J Physiol (2014) 0.83
Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol (2014) 0.83
Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract. Auton Neurosci (2013) 0.83
Irritable bowel syndrome and food interaction. World J Gastroenterol (2014) 0.82
Refractory inflammatory bowel disease-could it be an irritable bowel? Nat Rev Gastroenterol Hepatol (2012) 0.82
Dietary requirement for serum-derived bovine immunoglobulins in the clinical management of patients with enteropathy. Dig Dis Sci (2014) 0.82
Obesity and irritable bowel syndrome: a comprehensive review. Gastroenterol Hepatol (N Y) (2014) 0.82
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol (2014) 0.82
I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol (2014) 0.81
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
What's New in the Toolbox for Constipation and Fecal Incontinence? Front Med (Lausanne) (2014) 0.81
Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien Klin Wochenschr (2015) 0.81
Cognitive behavioral approach to understanding irritable bowel syndrome. World J Gastroenterol (2014) 0.81
Human colorectal mucosal microbiota correlates with its host niche physiology revealed by endomicroscopy. Sci Rep (2016) 0.81
Fecal microbiota transplantation in patients with slow-transit constipation: A randomized, clinical trial. PLoS One (2017) 0.81
Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. Am J Gastroenterol (2015) 0.80
The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench (2014) 0.80
Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt. BMJ Open Gastroenterol (2016) 0.79
A pilot study on the effect of a symbiotic mixture in irritable bowel syndrome: an open-label, partially controlled, 6-month extension of a previously published trial. Tech Coloproctol (2013) 0.79
Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome. BMC Complement Altern Med (2013) 0.79
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes (2015) 0.79
Overgrowth of the indigenous gut microbiome and irritable bowel syndrome. World J Gastroenterol (2014) 0.79
Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therap Adv Gastroenterol (2016) 0.78
Multispecies probiotic protects gut barrier function in experimental models. World J Gastroenterol (2014) 0.78
Is irritable bowel syndrome an infectious disease? World J Gastroenterol (2016) 0.78
Advances in IBS 2016: A Review of Current and Emerging Data. Gastroenterol Hepatol (N Y) (2016) 0.78
Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study. Int J Mol Sci (2016) 0.77
Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating. Am J Gastroenterol (2016) 0.77
Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. Am J Physiol Gastrointest Liver Physiol (2016) 0.77
Fecal biomarkers of intestinal health and disease in children. Front Pediatr (2014) 0.77
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls. Parasit Vectors (2015) 0.77
Five-year follow-up of 263 cases of functional bowel disorder. World J Gastroenterol (2013) 0.77
Microbial signatures in post-infectious irritable bowel syndrome - toward patient stratification for improved diagnostics and treatment. Gut Microbes (2015) 0.76
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol (2015) 0.76
Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up. United European Gastroenterol J (2015) 0.76
The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial. Adv Biomed Res (2014) 0.76
Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications. Clujul Med (2014) 0.75
Gut microbial diversity analysis using Illumina sequencing for functional dyspepsia with liver depression-spleen deficiency syndrome and the interventional Xiaoyaosan in a rat model. World J Gastroenterol (2017) 0.75
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Diversity of the human intestinal microbial flora. Science (2005) 49.64
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Development of the human infant intestinal microbiota. PLoS Biol (2007) 18.91
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 15.22
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr (1995) 13.30
Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res (2007) 13.08
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 11.21
An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature (2007) 10.92
Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol (1998) 10.67
Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03
The functional gastrointestinal disorders and the Rome III process. Gastroenterology (2006) 8.71
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 8.68
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
A catalog of reference genomes from the human microbiome. Science (2010) 8.10
Gut microbiota in health and disease. Physiol Rev (2010) 7.76
The gut flora as a forgotten organ. EMBO Rep (2006) 7.42
Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun (2003) 6.82
Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) (2009) 6.12
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology (2005) 5.75
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol (2000) 5.72
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol (2005) 5.62
Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2010) 5.43
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology (2007) 5.04
Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) (2008) 4.78
The role of psychological and biological factors in postinfective gut dysfunction. Gut (1999) 4.54
Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol (2010) 4.45
Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology (2001) 4.30
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil (2009) 4.28
High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut (2008) 4.10
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology (2004) 4.05
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2003) 3.84
Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol (1995) 3.77
Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One (2010) 3.64
Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A (2009) 3.58
Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol (2009) 3.57
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett (2004) 3.43
Shotgun metaproteomics of the human distal gut microbiota. ISME J (2008) 3.43
The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med (2006) 3.30
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 3.28
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol (2006) 3.24
Postinfectious irritable bowel syndrome. Gastroenterology (2009) 3.17
The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol (1982) 3.04
Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One (2010) 3.03
Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol (2006) 3.02
Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol (2002) 3.00
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol (2005) 2.99
Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis (2005) 2.93
Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol (2006) 2.93
Absorption of short-chain fatty acids by the colon. Gastroenterology (1980) 2.92
Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol (2002) 2.85
Oligonucleotide microchips as genosensors for determinative and environmental studies in microbiology. Appl Environ Microbiol (1997) 2.83
Prebiotics: the concept revisited. J Nutr (2007) 2.83
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut (2006) 2.82
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology (2011) 2.79
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 2.71
Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun (1995) 2.70
Bran and irritable bowel syndrome: time for reappraisal. Lancet (1994) 2.68
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology (2007) 2.63
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther (2007) 2.56
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut (2011) 2.49
Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Lab Invest (1970) 2.45
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol (2009) 2.39
Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One (2010) 2.39
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol (2001) 2.38
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther (2007) 2.38
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology (1999) 2.37
A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics (2010) 2.36
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut (2006) 2.24
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol (2010) 2.23
Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med (2011) 2.19
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med (2006) 2.16
Metatranscriptomic approach to analyze the functional human gut microbiota. PLoS One (2011) 2.14
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther (2008) 2.13
Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest (2007) 2.09
Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology (2006) 2.07
Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol (2010) 2.05
Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol (2010) 2.02
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol (2000) 2.00
Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest (1985) 2.00
Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther (2011) 1.97
The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology (2009) 1.94
Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol (2005) 1.93
Antibiotics increase functional abdominal symptoms. Am J Gastroenterol (2002) 1.92
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Functional bowel disorders. Gastroenterology (2006) 20.72
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett (2002) 7.29
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol (2002) 5.44
Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2010) 5.43
Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 4.45
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (2008) 4.12
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog (2012) 3.81
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett (2009) 3.48
Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol (2002) 3.43
Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol (2006) 3.39
Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol (2010) 3.32
Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol (2006) 3.30
From cellulosomes to cellulosomics. Chem Rec (2008) 2.78
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 2.71
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med (2005) 2.68
Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol (2004) 2.66
Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol (2009) 2.57
The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm Bowel Dis (2014) 2.46
Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol (2006) 2.43
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol (2002) 2.35
Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol (2006) 2.34
Chronic intestinal pseudo-obstruction. World J Gastroenterol (2008) 2.29
High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr (2011) 2.26
pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol (2005) 2.19
An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18
Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int J Syst Evol Microbiol (2002) 2.14
Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol (2004) 2.09
Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest (2007) 2.09
Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol (2002) 2.08
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice. J Physiol (2006) 2.07
A low-residue breakfast improves patient tolerance without impacting quality of low-volume colon cleansing prior to colonoscopy: a randomized trial. Am J Gastroenterol (2013) 2.06
Inflammatory neuropathies of the enteric nervous system. Gastroenterology (2004) 2.02
Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J (2012) 2.02
The safety profile of oral sodium phosphate for colonic cleansing before colonoscopy in adults. Gastrointest Endosc (2002) 2.02
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet (2008) 1.98
Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology (2009) 1.97
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol (2003) 1.92
The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One (2011) 1.90
Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol (2009) 1.89
The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol (2009) 1.87
Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr (2013) 1.87
Hybrid tet genes and tet gene nomenclature: request for opinion. Antimicrob Agents Chemother (2005) 1.86
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology (2010) 1.85
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology (2006) 1.85
Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol (2003) 1.77
Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol (2011) 1.76
Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol (2008) 1.75
Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol (2006) 1.75
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology (2006) 1.75
Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl Environ Microbiol (2003) 1.74
The influence of diet on the gut microbiota. Pharmacol Res (2012) 1.74
Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology (2011) 1.70
Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr (2004) 1.70
Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology (2006) 1.69
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 1.67
Selective colonization of insoluble substrates by human faecal bacteria. Environ Microbiol (2007) 1.63
Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int J Syst Evol Microbiol (2006) 1.62
Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res Microbiol (2006) 1.61
Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol (2011) 1.60
The intestinal LABs. Antonie Van Leeuwenhoek (2002) 1.60
High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol (2010) 1.59
Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors. Hepatology (2007) 1.55
Enteric neuroplasticity evoked by inflammation. Auton Neurosci (2006) 1.55
Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol (2012) 1.54
Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med (2009) 1.53
Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 1.52
Gender and irritable bowel syndrome: the male connection. J Clin Gastroenterol (2004) 1.50
Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology (2002) 1.50
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology (2009) 1.50
Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper. Can J Gastroenterol (2006) 1.49
Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol (2007) 1.45
Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol (2005) 1.42
Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol (2009) 1.42
Comparative analysis of sequences flanking tet(W) resistance genes in multiple species of gut bacteria. Antimicrob Agents Chemother (2006) 1.42
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol (2011) 1.41
Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2004) 1.41
Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol (2012) 1.40
Fewer polyps detected by colonoscopy as the day progresses at a Veteran's Administration teaching hospital. Clin Gastroenterol Hepatol (2009) 1.39
Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol (2002) 1.39
The Butyrivibrio fibrisolvens tet(W) gene is carried on the novel conjugative transposon TnB1230, which contains duplicated nitroreductase coding sequences. J Bacteriol (2004) 1.38
Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol (2006) 1.38
Diversity and strain specificity of plant cell wall degrading enzymes revealed by the draft genome of Ruminococcus flavefaciens FD-1. PLoS One (2009) 1.37
Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am (2005) 1.35
Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J (2012) 1.34
Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One (2009) 1.32
Novel organization and divergent dockerin specificities in the cellulosome system of Ruminococcus flavefaciens. J Bacteriol (2003) 1.32
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) (2013) 1.31
Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol (2011) 1.31
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut (2012) 1.30
The species composition of the human intestinal microbiota differs between particle-associated and liquid phase communities. Environ Microbiol (2008) 1.28
Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol (2003) 1.28
In vivo imaging of intragastric gelation and its effect on satiety in humans. J Nutr (2004) 1.28